NDAORALCAPSULE
Approved
Sep 2024
Lifecycle
Growth
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
Cholinergic Muscarinic Agonists
Pharmacologic Class:
Cholinergic Muscarinic Agonist
Indications (2)
Clinical Trials (2)
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Started Apr 2026
12 enrolled
SCHIZOPHRENIA 1 (Disorder)Schizoaffecitve Disorder
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Started Feb 2026
1,500 enrolled
Schizophrenia
Loss of Exclusivity
LOE Date
Sep 27, 2039
165 months away
Patent Expiry
Sep 27, 2039
Exclusivity Expiry
Sep 26, 2029